Page last updated: 2024-08-23

4-methoxyamphetamine and butylscopolammonium bromide

4-methoxyamphetamine has been researched along with butylscopolammonium bromide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's5 (83.33)2.80

Authors

AuthorsStudies
Aielli, F; Marinangeli, F; Masedu, F; Massici, A; Mercadante, S; Russo, D; Ursini, L; Valenti, M1
Boogaard, R; Geijteman, ECT; Huisman, BAA; Noordzij-Nooteboom, HS; Oomen-de Hoop, E; van der Heide, A; van der Rijt, CCD; van Esch, HJ; van Zuylen, L1
Prins, SD; van de Vathorst, S; van der Heide, A; van der Rijt, CCD; van Esch, HJ; van Zuylen, L1
van der Rijt, CCD; van Esch, HJ; van Zuylen, L1
Abe, A; Amano, K; Ishiki, H1
Mechineni, A1

Reviews

1 review(s) available for 4-methoxyamphetamine and butylscopolammonium bromide

ArticleYear
Reflections on Including Patients in a Randomized Placebo-Controlled Multicentre Trial in the Dying Phase - the SILENCE Study.
    Journal of pain and symptom management, 2022, Volume: 63, Issue:5

    Topics: Butylscopolammonium Bromide; Death; Hospice Care; Hospitalization; Humans; Informed Consent; Multicenter Studies as Topic; Randomized Controlled Trials as Topic

2022

Trials

2 trial(s) available for 4-methoxyamphetamine and butylscopolammonium bromide

ArticleYear
Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later.
    Journal of pain and symptom management, 2018, Volume: 56, Issue:6

    Topics: Aged; Butylscopolammonium Bromide; Death; Disease Management; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Male; Neoplasms; Palliative Care; Parasympatholytics; Respiratory Sounds; Terminal Care; Treatment Outcome

2018
Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life: The SILENCE Randomized Clinical Trial.
    JAMA, 2021, 10-05, Volume: 326, Issue:13

    Topics: Aged; Aged, 80 and over; Butylscopolammonium Bromide; Cholinergic Antagonists; Confidence Intervals; Death; Double-Blind Method; Drug Administration Schedule; Female; Hospice Care; Humans; Incidence; Informed Consent; Injections, Subcutaneous; Life Expectancy; Male; Middle Aged; Netherlands; Placebos; Proportional Hazards Models; Respiratory Sounds; Treatment Outcome

2021

Other Studies

3 other study(ies) available for 4-methoxyamphetamine and butylscopolammonium bromide

ArticleYear
Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life-Reply.
    JAMA, 2022, 01-18, Volume: 327, Issue:3

    Topics: Butylscopolammonium Bromide; Death; Humans; Hydrocarbons, Brominated

2022
Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life.
    JAMA, 2022, 01-18, Volume: 327, Issue:3

    Topics: Butylscopolammonium Bromide; Death; Humans; Hydrocarbons, Brominated

2022
Prophylactic scopolamine butylbromide reduced death rattle in patients in the dying phase.
    Annals of internal medicine, 2022, Volume: 175, Issue:3

    Topics: Butylscopolammonium Bromide; Death; Humans; Hydrocarbons, Brominated; Scopolamine

2022